Department of Neurosurgery, Tufts Medical Center, Boston, Massachusetts, USA.
Division of Endocrinology, Diabetes and Metabolism, Hypothalamic and Pituitary Disease Center, Tufts Medical Center, Boston, Massachusetts, USA.
World Neurosurg. 2024 Oct;190:e223-e229. doi: 10.1016/j.wneu.2024.07.095. Epub 2024 Jul 18.
Hyponatremia is a common complication following endoscopic endonasal resection (EER) of pituitary adenomas. We report a single-center, multisurgeon study detailing baseline clinical data, outcomes, and factors associated with postoperative hyponatremia.
This was a retrospective cohort study of patients undergoing EER for pituitary adenoma at Tufts Medical Center. Most procedures were performed by the senior author (C.B.H.). Cases were included if at least 1 postoperative sodium value was available and pathology confirmed pituitary adenoma. Hyponatremia was defined as a postoperative sodium level <135 mEq/L.
A total of 272 patients underwent 310 EER procedures that met the study inclusion criteria. The mean patient age was 53.3 years, and mean tumor size was 18.8 mm. Postoperative hyponatremia occurred in 12.6% of cases, with 3.6% developing hyponatremia prior to discharge. Lower preoperative sodium level was associated with an increased risk of developing any postoperative hyponatremia. Older age, prolactinoma pathology, and use of selective serotonin reuptake inhibitors were associated with moderate to severe hyponatremia (≤129 mEq/L), and lower preoperative sodium was associated with mild hyponatremia (130-134 mEq/L). Hyponatremia-related readmissions within 30 days occurred in 3.9% of patients. Both African-American race and postoperative hyponatremia were associated with an increased risk of 30-day readmission. The mean nadir sodium for hyponatremic patients was 129.9 mEq/L. Growth hormone-secreting pathology was associated with lower postoperative nadir sodium, whereas higher preoperative sodium was associated with higher postoperative nadir sodium.
Hyponatremia is a common postoperative complication of EER for pituitary lesions that can cause significant morbidity, increased readmissions, and increased healthcare costs.
内镜经鼻蝶窦入路垂体瘤切除术(EER)后低钠血症是一种常见的并发症。我们报告了一项单中心、多外科医生的研究,详细描述了基线临床数据、结果以及与术后低钠血症相关的因素。
这是一项回顾性队列研究,纳入在塔夫茨医疗中心接受 EER 治疗的垂体瘤患者。大多数手术由资深作者(C.B.H.)完成。如果至少有 1 个术后钠值且病理证实为垂体腺瘤,则纳入病例。低钠血症定义为术后血清钠水平<135 mEq/L。
共有 272 例患者接受了符合研究纳入标准的 310 例 EER 手术。患者平均年龄为 53.3 岁,肿瘤平均大小为 18.8 mm。术后低钠血症的发生率为 12.6%,其中 3.6%在出院前发生低钠血症。术前血清钠水平较低与发生任何术后低钠血症的风险增加相关。年龄较大、催乳素瘤病理和使用选择性 5-羟色胺再摄取抑制剂与中重度低钠血症(≤129 mEq/L)相关,而术前血清钠水平较低与轻度低钠血症(130-134 mEq/L)相关。术后 30 天内因低钠血症相关再入院的患者有 3.9%。非裔美国人种族和术后低钠血症均与 30 天内再入院的风险增加相关。低钠血症患者的平均血清钠最低值为 129.9 mEq/L。生长激素分泌性肿瘤与术后血清钠最低值较低相关,而术前血清钠水平较高与术后血清钠最低值较高相关。
EER 治疗垂体病变后低钠血症是一种常见的术后并发症,可导致显著的发病率、再入院率增加和医疗保健费用增加。